Priority Blood Work for Suspected Syphilis
For patients suspected of having syphilis, the priority blood work should include both nontreponemal (RPR or VDRL) and treponemal tests, with the nontreponemal test typically performed first in the traditional algorithm. 1
Diagnostic Algorithm
Initial Testing
Nontreponemal test (first-line screening):
- Rapid Plasma Reagin (RPR) or
- Venereal Disease Research Laboratory (VDRL) test
Treponemal-specific test (confirmation if nontreponemal test is positive):
- Fluorescent Treponemal Antibody Absorption (FTA-ABS)
- T. pallidum Particle Agglutination (TP-PA)
Alternative Approach (Reverse Sequence)
Some laboratories use the reverse sequence algorithm:
- Treponemal test first (screening)
- Nontreponemal test (if treponemal test is positive)
- Second treponemal test (if discordant results)
Test Performance by Stage of Disease
Primary Syphilis
- Nontreponemal tests have variable sensitivity:
- False negatives are common in early primary syphilis
Secondary Syphilis
Latent Syphilis
Special Considerations
HIV Co-infection Testing
- HIV testing should be performed in all patients with suspected syphilis due to:
- High co-infection rates
- Altered presentation in HIV-positive patients
- Potential impact on treatment and follow-up 1
Additional Testing Based on Clinical Presentation
For suspected neurosyphilis: Lumbar puncture for CSF analysis
For pregnant patients: More frequent serologic testing and closer follow-up 1
Common Pitfalls and Caveats
Prozone phenomenon: False-negative results in high-titer specimens
- Solution: Request dilution testing if clinical suspicion is high
Biological false positives: Can occur in 0.8-1.3% of the general population due to:
- Autoimmune disorders
- Pregnancy
- IV drug use
- Viral infections (HCV, HIV) 1
Test selection issues:
- RPR and VDRL titers are not directly comparable
- Switching between test types during follow-up should be avoided
Seronegative window period:
- Early primary syphilis may have negative serologic tests
- Consider direct detection methods (dark-field microscopy or PCR) for genital lesions
Follow-up Testing
After treatment, quantitative nontreponemal tests should be performed at:
- 3 months
- 6 months
- 9 months
- 12 months
A four-fold decline in titer (e.g., 1:32 to 1:8) indicates adequate treatment response 1, 4.
Conclusion
The combination of nontreponemal and treponemal tests is essential for accurate diagnosis of syphilis, with test selection guided by clinical presentation and stage of disease. High-titer RPR (≥1:32) is associated with increased risk of neurosyphilis, particularly in HIV-infected patients with CD4+ counts ≤350 cells/μL 5.